Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Safety Study of the Application of CRIS100 in Participants With Acute Spinal Cord Injury

NCT05739734 is registered in ClinicalTrials.gov with Cristália Produtos Químicos Farmacêuticos Ltda. as lead sponsor.

NCT NCT05739734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05739734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Safety Study of the Application of CRIS100 in Participants With Acute Spinal Cord Injury
Lead sponsor
Cristália Produtos Químicos Farmacêuticos Ltda.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
May 31, 2027
Enrollment
5 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

thoracic spinal cord injury